Therapeutic potential of urine-derived stem cells in renal regeneration following acute kidney injury: A comparative analysis with mesenchymal stem cells

Figure 8 Angiogenesis-related protein growth factor secretion by urine-derived stem cells and bone marrow mesenchymal stem cells. A: Results of angiogenesis growth factor secretion by urine-derived stem cells (USCs); B: Results of angiogenesis growth factor secretion by bone marrow mesenchymal stem cells (BMSCs); C: Statistical analysis of the levels of secretion by USCs and BMSCs by using Student’s t test: ^aP < 0. 05, urine-derived stem cell vs bone marrow mesenchymal stem cell. USC: Urine-derived stem cell; BMSC: Bone marrow mesenchymal stem cell; EG-VEGF: Endocrine gland-derived vascular endothelial growth factor; EGF: Epidermal growth factor; FGF: Fibroblast growth factor; HGF: Hepatocyte growth factor; IGFBP: Insulin-like growth factor binding protein; MCP: Monocyte chemoattractant protein; MMP: Matrix metalloproteinase; PD-ECGF: Platelet-derived endothelial cell growth factor; PIGF: Placental growth factor; TIMP: Tissue inhibitor of metalloproteinases; TGF: Transforming growth factor; uPA: Urokinase plasminogen activator.